ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 1, 2021
Clear
SKU: GMS-1196 Category:

OVERVIEW

The market for ELISpot and FluoroSpot is projected to hit USD 453 million by 2026, rising at a CAGR of 14.3% over the forecast period, owing to the COVID-19 pandemic. The rising global incidence of chronic diseases, increased vaccine production to tackle antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers are all driving this market forward. In addition, t he effect of the COVID-19 outbreak on the industry will be thoroughly evaluated in the following report. The study also contrasts the pre-COVID-19 and post-COVID-19 markets.

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 1

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 2

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 3

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 4

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 5

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 6

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 7

ELISpot and FluoroSpot Assay Market by Product (Ancillary Products, Assay Kit (B Cell assay and T Cell), Analyzer), End User (Labs, Research Institute, Hospital), Application (Vaccines, Transplant, Cancer, Clinical Trials) – 2021 to 2026 8

TABLE OF CONTENT

1 Global ELISpot and FluoroSpot Assay Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global ELISpot and FluoroSpot Assay Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global ELISpot and FluoroSpot Assay Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global ELISpot and FluoroSpot Assay Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global ELISpot and FluoroSpot Assay Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global ELISpot and FluoroSpot Assay Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global ELISpot and FluoroSpot Assay Market – By Product (Market Size – & million/billion)
8.1 Assay Kits
8.2 Analyzers
8.3 Ancillary Products

9 Global ELISpot and FluoroSpot Assay Market – By Application
9.1 Diagnostic Applications
9.2 Research Applications

10 Global ELISpot and FluoroSpot Assay Market – By End-User
10.1 Hospitals & Clinical Laboratories
10.2 Research Institutes
10.3 Biopharmaceutical Companies

11 Global ELISpot and FluoroSpot Assay Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global ELISpot and FluoroSpot Assay Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global ELISpot and FluoroSpot Assay Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Oxford Immunotec
13.3 Cellular Technology Limited (CTL)
13.4 Mabtech AB
13.5 Becton, Dickinson and Company
13.6 Abcam
13.7 U-Cytech Biosciences
13.8 Bio-Techne
13.9 Biotech Investissement Group
13.10 Autoimmun Diagnostika GmbH
13.11 Lophius Biosciences GmbH
13.12 Company 11 & more

14 Global ELISpot and FluoroSpot Assay Market – Appendix
14.1 Sources
14.2 Abbreviations